Matches in Wikidata for { <http://www.wikidata.org/entity/Q89507569> ?p ?o ?g. }
Showing items 1 to 47 of
47
with 100 items per page.
- Q89507569 description "clinical trial" @default.
- Q89507569 description "ensayo clínico" @default.
- Q89507569 description "ensayu clínicu" @default.
- Q89507569 description "klinisch onderzoek" @default.
- Q89507569 description "клінічне випробування" @default.
- Q89507569 name "Clinical Trial of Combined Use of Hydroxychloroquine, Azithromycin, and Tocilizumab for the Treatment of COVID-19" @default.
- Q89507569 name "Clinical Trial of Combined Use of Hydroxychloroquine, Azithromycin, and Tocilizumab for the Treatment of COVID-19" @default.
- Q89507569 name "Clinical Trial of Combined Use of Hydroxychloroquine, Azithromycin, and Tocilizumab for the Treatment of COVID-19" @default.
- Q89507569 type Item @default.
- Q89507569 label "Clinical Trial of Combined Use of Hydroxychloroquine, Azithromycin, and Tocilizumab for the Treatment of COVID-19" @default.
- Q89507569 label "Clinical Trial of Combined Use of Hydroxychloroquine, Azithromycin, and Tocilizumab for the Treatment of COVID-19" @default.
- Q89507569 label "Clinical Trial of Combined Use of Hydroxychloroquine, Azithromycin, and Tocilizumab for the Treatment of COVID-19" @default.
- Q89507569 prefLabel "Clinical Trial of Combined Use of Hydroxychloroquine, Azithromycin, and Tocilizumab for the Treatment of COVID-19" @default.
- Q89507569 prefLabel "Clinical Trial of Combined Use of Hydroxychloroquine, Azithromycin, and Tocilizumab for the Treatment of COVID-19" @default.
- Q89507569 prefLabel "Clinical Trial of Combined Use of Hydroxychloroquine, Azithromycin, and Tocilizumab for the Treatment of COVID-19" @default.
- Q89507569 P1050 Q89507569-b6be639c-48ad-d421-5eef-52a3e8ff8a06 @default.
- Q89507569 P1132 Q89507569-9928AFCA-CD13-4552-83E7-785DB2B62D77 @default.
- Q89507569 P1476 Q89507569-437AFC67-D516-4CC6-B2FC-80156461D045 @default.
- Q89507569 P1813 Q89507569-EFC43CEE-FC85-49A4-8C91-7328E4809AA9 @default.
- Q89507569 P2899 Q89507569-4A8C7126-8C97-4FE9-ADC6-09F791AA9F0B @default.
- Q89507569 P3098 Q89507569-F77E2443-82F6-4328-A8CD-880ED6D1D509 @default.
- Q89507569 P31 Q89507569-92E2C76A-8FFC-46A1-9DBD-DA376557B149 @default.
- Q89507569 P4844 Q89507569-14497772-0BB2-44CD-B79A-30729214CE73 @default.
- Q89507569 P4844 Q89507569-850c98d8-4b74-e304-030b-a3143ff3d1d4 @default.
- Q89507569 P4844 Q89507569-c0589330-4774-85c3-158e-c7fd7845e925 @default.
- Q89507569 P580 Q89507569-CC5612B1-A06C-4830-823C-4ABF78E3CD72 @default.
- Q89507569 P582 Q89507569-7C5BDD2A-DA83-42AC-9788-7D7A436AAE11 @default.
- Q89507569 P6099 Q89507569-1A2F861D-98F0-40F3-B4DF-86CA3D1D6588 @default.
- Q89507569 P8363 Q89507569-9DF5C721-20F8-43BD-8E40-7AD3F3D0FCDE @default.
- Q89507569 P921 Q89507569-2b03bab2-4751-f9b0-ea92-b0eb62751875 @default.
- Q89507569 P921 Q89507569-6AE044D1-B016-46A0-AA65-84F9895BE7AD @default.
- Q89507569 P1050 Q84263196 @default.
- Q89507569 P1132 "+276" @default.
- Q89507569 P1476 "Pilot, Randomized, Multicenter, Open-label Clinical Trial of Combined Use of Hydroxychloroquine, Azithromycin, and Tocilizumab for the Treatment of SARS-CoV-2 Infection (COVID-19)" @default.
- Q89507569 P1813 "TOCOVID" @default.
- Q89507569 P2899 "+18" @default.
- Q89507569 P3098 "NCT04332094" @default.
- Q89507569 P31 Q30612 @default.
- Q89507569 P4844 Q165399 @default.
- Q89507569 P4844 Q421094 @default.
- Q89507569 P4844 Q425154 @default.
- Q89507569 P580 "2020-04-01T00:00:00Z" @default.
- Q89507569 P582 "2020-09-01T00:00:00Z" @default.
- Q89507569 P6099 Q42824440 @default.
- Q89507569 P8363 Q78089383 @default.
- Q89507569 P921 Q82069695 @default.
- Q89507569 P921 Q84263196 @default.